全文获取类型
收费全文 | 416篇 |
免费 | 23篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 7篇 |
妇产科学 | 3篇 |
基础医学 | 59篇 |
口腔科学 | 42篇 |
临床医学 | 27篇 |
内科学 | 51篇 |
皮肤病学 | 3篇 |
神经病学 | 17篇 |
特种医学 | 9篇 |
外科学 | 71篇 |
综合类 | 22篇 |
预防医学 | 29篇 |
眼科学 | 23篇 |
药学 | 24篇 |
中国医学 | 3篇 |
肿瘤学 | 43篇 |
出版年
2024年 | 3篇 |
2023年 | 4篇 |
2022年 | 11篇 |
2021年 | 27篇 |
2020年 | 7篇 |
2019年 | 6篇 |
2018年 | 11篇 |
2017年 | 10篇 |
2016年 | 13篇 |
2015年 | 11篇 |
2014年 | 17篇 |
2013年 | 25篇 |
2012年 | 39篇 |
2011年 | 32篇 |
2010年 | 32篇 |
2009年 | 14篇 |
2008年 | 16篇 |
2007年 | 19篇 |
2006年 | 28篇 |
2005年 | 21篇 |
2004年 | 19篇 |
2003年 | 18篇 |
2002年 | 10篇 |
2001年 | 4篇 |
2000年 | 6篇 |
1999年 | 7篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1993年 | 6篇 |
1992年 | 4篇 |
1991年 | 4篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1984年 | 1篇 |
1981年 | 1篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1969年 | 1篇 |
排序方式: 共有440条查询结果,搜索用时 109 毫秒
61.
Eduardo Sanchez;Elizabeth M Krantz;Leah Yoke;Molly Gallaher;Pooja Bhattacharyya;Lisa So;Zahra Kassamali Escobar;Frank Tverdek;Emily A Rosen;ZZ Quinn;Michelle Swetky;Salma Walji;Marie H. Wilson;Brittany McCreery;Denise McCulloch;Amelia Weixler;Pavitra Roychoudhury;Steven A Pergam;Catherine Liu; 《Transplant infectious disease》2024,26(1):e14223
There are limited data on clinical outcomes associated with the use of bebtelovimab for the treatment of coronavirus disease 2019 (COVID-19) among cancer patients. We aimed to define the clinical characteristics and outcomes among patients receiving bebtelovimab as part of the COVID-19 therapeutics program at our cancer center. 相似文献
62.
Lasata Shrestha Michelle J. Lin Hong Xie Margaret G. Mills Shah A. Mohamed Bakhash Vinod P. Gaur Robert J. Livingston Jared Castor Emily A. Bruce Jason W. Botten Meei-Li Huang Keith R. Jerome Alexander L. Greninger Pavitra Roychoudhury 《The Journal of molecular diagnostics : JMD》2022,24(9):963-976
Amplicon-based sequencing methods are central in characterizing the diversity, transmission, and evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but need to be rigorously assessed for clinical utility. Herein, we validated the Swift Biosciences'' SARS-CoV-2 Swift Normalase Amplicon Panels using remnant clinical specimens. High-quality genomes meeting our established library and sequence quality criteria were recovered from positive specimens, with 95% limit of detection of 40.08 SARS-CoV-2 copies/PCR. Breadth of genome recovery was evaluated across a range of CT values (11.3 to 36.7; median, 21.6). Of 428 positive samples, 413 (96.5%) generated genomes with <10% unknown bases, with a mean genome coverage of 13,545× ± SD 8382×. No genomes were recovered from PCR-negative specimens (n = 30) or from specimens positive for non–SARS-CoV-2 respiratory viruses (n = 20). Compared with whole-genome shotgun metagenomic sequencing (n = 14) or Sanger sequencing for the spike gene (n = 11), pairwise identity between consensus sequences was 100% in all cases, with highly concordant allele frequencies (R2 = 0.99) between Swift and shotgun libraries. When samples from different clades were mixed at varying ratios, expected variants were detected even in 1:99 mixtures. When deployed as a clinical test, 268 tests were performed in the first 23 weeks, with a median turnaround time of 11 days, ordered primarily for outbreak investigations and infection control.Since the deposition of the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whole genome sequence (NC_045512.1) in January 2020, >4 million SARS-CoV-2 genomes have been deposited to public data repositories, far exceeding any other human pathogen.1,2 Such a feat has been made possible because of advances in next-generation sequencing (NGS) technologies that enable near real-time genomic surveillance.3, 4, 5, 6, 7, 8, 9 Viral whole-genome sequencing (WGS) of laboratory-confirmed SARS-CoV-2 isolates is frequently used in outbreak investigations, deployment of public health interventions, development of vaccines and therapeutics, and evaluation of vaccine and antiviral effectiveness against emerging variants.4, 5, 6,10, 11, 12, 13, 14, 15 Specific SARS-CoV-2 variants have been associated with higher viral loads, lower vaccine effectiveness, and worse outcomes, such as mortality.16, 17, 18, 19, 20, 21, 22, 23 Notably, B.1.1.7 has been associated with increased disease severity, prolonged hospitalization, and higher mortality risk.16,18,19,21, 22, 23, 24 In addition, recent studies have shown poorer outcomes for patients infected with variants B.1.351 and P.1.23,25 In a clinical setting, identification of specific viral mutations can aid in the selection of monoclonal therapies,26, 27, 28, 29 and viral sequencing can be used to monitor the accumulation of mutations during long-term viral replication in immunocompromised individuals.30 As treatment regimens expand, validated WGS assays are needed not only for genomic surveillance but also for high-quality, clinically actionable data with rapid turnaround times.Multiplexed amplicon sequencing methods have proven to be faster, more sensitive, and more cost-effective than shotgun and capture-based approaches, enabling genome recovery across a wide range of viral loads.31,32 We previously tested one such panel from Swift Biosciences and demonstrated genome recovery up to a CT of 36 across a broad range of isolates.33 Designed against the SARS-CoV-2 Wuhan–Hu-1 complete genome (https://www.ncbi.nlm.nih.gov/nuccore, accession number , last accessed July 12, 2022), the Swift Normalase Amplicon Panel (SNAP) primer set amplifies 345 amplicons ranging from 116 to 255 bp (average, 150 bp) in a single tube to cover the approximately 30-kb SARS-CoV-2 genome. This assay can generate libraries in <3 hours using an input concentration of only 10 to 100+ viral copies for single-strand cDNA or double-strand cDNA synthesis. This can be followed by either manual normalization or Swift Biosciences'' proprietary enzymatic normalization of multiplexed libraries for equimolar pools.For clinical use, sequencing assays need to be rigorously validated, documented, and performed in Clinical Laboratory Improvement Amendments–accredited laboratories. However, no specific guidelines currently exist for the development and validation of WGS assays for SARS-CoV-2. We validated the Swift Biosciences'' one-tube SARS-CoV-2 SNAP Version 2.0—the first clinical validation of an NGS-based assay for WGS of SARS-CoV-2 to our knowledge—according to US Food and Drug Administration’s “Considerations for Design, Development, and Analytical Validation of Next Generation Sequencing-Based in Vitro Diagnostics Intended to Aid in the Diagnosis of Suspected Germline Diseases” ( NC_045512.2https://www.fda.gov/media/99208/download, last accessed January 4, 2021) and US Food and Drug Administration''s “Submitting Next Generation Sequencing Data to the Division of Antiviral Products Guidance for Industry” Technical Specifications Document (https://www.fda.gov/regulatory-information/search-fda-guidance-documents/submitting-next-generation-sequencing-data-division-antiviral-products-guidance-industry-technical, last accessed August 19, 2021). Using clinical specimens, the analytical sensitivity, analytical specificity, limit of detection, accuracy, and precision (reproducibility and repeatability) of the assay were evaluated, establishing acceptance criteria for sequencing libraries and output genomes. This assay is now available as a clinically orderable test, with results returned to physicians to aid in disease management and treatment. It has been used in multiple vaccine trials, research studies, validation of other NGS-based assays, and sequencing SARS-CoV-2 for public health surveillance and outbreak investigation.4,6,10,34, 35, 36, 37, 38 相似文献
63.
Jussi Pekka Tolonen;Ricardo Parolin Schnekenberg;Simon McGowan;David Sims;Meriel McEntagart;Frances Elmslie;Debbie Shears;Helen Stewart;George K. Tofaris;Tabib Dabir;Patrick J. Morrison;Diana Johnson;Marios Hadjivassiliou;Sian Ellard;Charles Shaw-Smith;Anna Znaczko;Abhijit Dixit;Mohnish Suri;Ajoy Sarkar;Rachel E. Harrison;Gabriela Jones;Henry Houlden;Giorgia Ceravolo;Joanna Jarvis;Jonathan Williams;Morag E. Shanks;Penny Clouston;Julia Rankin;Lubov Blumkin;Tally Lerman-Sagie;Penina Ponger;Salmo Raskin;Katariina Granath;Johanna Uusimaa;Hector Conti;Emma McCann;Shelagh Joss;Alexander J.M. Blakes;Kay Metcalfe;Helen Kingston;Marta Bertoli;Rachel Kneen;Sally Ann Lynch;Inmaculada Martínez Albaladejo;Austen Peter Moore;Wendy D. Jones; ;Esther B.E. Becker;Andrea H. Németh; 《Movement disorders》2024,39(1):141-151
The ITPR1 gene encodes the inositol 1,4,5-trisphosphate (IP3) receptor type 1 (IP3R1), a critical player in cerebellar intracellular calcium signaling. Pathogenic missense variants in ITPR1 cause congenital spinocerebellar ataxia type 29 (SCA29), Gillespie syndrome (GLSP), and severe pontine/cerebellar hypoplasia. The pathophysiological basis of the different phenotypes is poorly understood. 相似文献
64.
Firefighting is a stressful and hazardous job. Persons engaged in firefighting are highly exposed to work-related stress as well as to smoke containing a host of chemicals potentially harmful to human health. In order to elucidate whether firefighting affects neuroendocrine and behavioral responses of firefighters, plasma catecholamine (CA) levels and the prevalence of neurobehavioral symptoms in 62 firefighters (all males, mean age 43 yr) and 52 control subjects matched for age and sex were examined in this study. Self-reported neurobehavioral symptoms data were obtained from a questionnaire survey and personal interview. Concentrations of epinephrine (E), norepinephrine (NE) and dopamine (DA) in plasma were measured by high-performance liquid chromatography with electrochemical detection. Compared with matched controls, the firefighters showed higher prevalence (p<0.05) of neurobehavioral symptoms such as burning sensation in the extremities, tingling and numbness, transient loss of memory, and depression, but no significant difference was recorded in the prevalences of anxiety, vertigo and dizziness. The firefighters demonstrated a more than two-fold (p<0.05) rise in plasma levels of E and NE, but the plasma DA level was relatively unchanged. Controlling age and smoking as possible confounders, firefighting was found to be associated with raised E (OR=2.15; 95% CI, 0.98-4.52), and NE levels (OR=2.24 95% CI, 1.22-3.61). In conclusion, the job of firefighting appears to be associated with stimulation of sympathetic activity and a rise in the prevalence of neurobehavioral symptoms. 相似文献
65.
Expression in Escherichia coli of biologically active enzyme by a DNA sequence coding for the human plasminogen activator urokinase. 总被引:5,自引:5,他引:0
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
66.
Ramesh P Avadhani A Shetty AP Dheenadhayalan J Rajasekaran S 《Journal of pediatric orthopedics. Part B》2011,20(3):124-128
The management of a persistent pink pulseless hand after a satisfactory closed reduction in a pediatric supracondylar fracture of the humerus is controversial. Several recent publications have recommended vascular exploration in contrast to a more conservative approach accepted traditionally. We report the results of seven patients with a mean follow-up of 36.6 months with a persistent pulseless, but well-perfused hand postreduction. All patients were managed conservatively without vascular exploration. A palpable return of the radial pulse was seen in six patients at 3 weeks and at 6 weeks follow-up in the other patient with no long-term dysfunction. We believe that the management of a persistent pink pulseless hand remains a 'watchful expectancy'. Surgical exploration should be recommended only if there is either severe pain in the forearm persisting for more than 12 h after the injury or if there are signs of a deteriorating neurological function. 相似文献
67.
Garcia CJ Dias A Hejazi RA Burgos JD Huerta A Zuckerman MJ 《The American journal of the medical sciences》2011,341(5):411-413
Epiphrenic diverticula are outpouchings of the esophagus that retain some or all layers of the esophageal wall. Symptoms such as intermittent dysphagia and vomiting may occur. The authors present a case of an elderly woman with a history of dysphagia who presented with a massive upper gastrointestinal bleed because of a bleeding epiphrenic diverticulum seen at endoscopy who responded to conservative management. Bleeding epiphrenic diverticula should be considered as a cause of upper gastrointestinal bleeding. 相似文献
68.
69.